| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 仰佳佳 | 申万宏源 | 医药生物 | 23.92% | 31.53% | 24.00% | 23.08% | 0 | -37.64% | 2025-05-15 |
| 2 | 马云涛 | 国元证券 | 医药生物 | 23.88% | 14.77% | 21.70% | -17.65% | 3 | -47.07% | 2025-06-12 |
| 3 | 李安飞 | 广发证券 | 医药生物 | 23.84% | 24.08% | 20.90% | -2.86% | 1 | -56.96% | 2025-04-17 |
| 4 | 张林晚 | 上海证券 | 医药生物 | 23.72% | 22.58% | 14.24% | -100.00% | 1 | -18.93% | 2025-06-26 |
| 5 | 武煜 | 招银国际 | 医药生物 | 23.70% | 16.29% | 2.91% | -33.33% | 2 | -16.66% | 2025-06-16 |
| 6 | 王班 | 民生证券 | 医药生物 | 23.66% | 14.60% | 15.58% | -21.43% | 15 | -61.25% | 2025-06-10 |
| 7 | 仰佳佳 | 申万宏源 | 医药生物 | 23.60% | 24.70% | 13.71% | 23.08% | 1 | -37.64% | 2025-05-27 |
| 8 | 华挺 | 财通证券 | 医药生物 | 23.60% | 22.48% | 6.74% | -6.67% | 4 | -50.33% | 2025-06-27 |
| 9 | 阳景 | 浦银国际证券 | 医药生物 | 23.59% | 63.56% | 20.51% | 100.00% | 2 | 0.00% | 2025-03-24 |
| 10 | 夏禹 | 国联民生 | 医药生物 | 23.58% | 20.18% | 26.51% | 20.00% | 6 | -52.01% | 2025-04-03 |
| 11 | 吴春红 | 江海证券 | 医药生物 | 23.58% | 11.99% | 24.11% | 27.27% | 10 | -25.67% | 2025-04-25 |
| 12 | 袁聪敏 | 中信证券 | 医药生物 | 23.53% | 16.66% | 15.78% | 100.00% | 1 | 0.00% | 2025-05-13 |
| 13 | 马云涛 | 国元证券 | 医药生物 | 23.53% | 16.04% | 22.97% | -17.65% | 3 | -47.07% | 2025-06-04 |
| 14 | 武煜 | 招银国际 | 医药生物 | 23.51% | 30.81% | 23.01% | -33.33% | 3 | -16.66% | 2025-04-29 |
| 15 | 韩世通 | 中信证券 | 医药生物 | 23.51% | 12.93% | 12.19% | -2.04% | 3 | -63.25% | 2025-06-10 |
| 16 | 阳景 | 浦银国际证券 | 医药生物 | 23.51% | 56.87% | 21.85% | 100.00% | 2 | 0.00% | 2025-03-21 |
| 17 | 刘浩 | 华创证券 | 医药生物 | 23.50% | 42.94% | 25.19% | 29.41% | 1 | -47.33% | 2025-03-26 |
| 18 | 唐寅灏 | 中信证券 | 医药生物 | 23.49% | 19.72% | 27.74% | 85.71% | 9 | -8.47% | 2025-04-23 |
| 19 | 吴春红 | 江海证券 | 医药生物 | 23.48% | 12.10% | 24.93% | 27.27% | 10 | -25.67% | 2025-04-30 |
| 20 | 武煜 | 招银国际 | 医药生物 | 23.47% | 22.11% | 23.48% | -33.33% | 2 | -16.66% | 2025-05-07 |